Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB

Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
11 Jul 2024
Historique:
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 11 7 2024
Statut: aheadofprint

Résumé

The cannabinoid receptor type 1 (CB

Identifiants

DOI: 10.1021/acs.jmedchem.4c00465 PMID: 38990855
pubmed: 38990855
doi: 10.1021/acs.jmedchem.4c00465
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Leonard Mach (L)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Anahid Omran (A)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Jara Bouma (J)

Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands.
ORCID: 0000-0002-6572-6158

Silke Radetzki (S)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

David A Sykes (DA)

Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, NG7 2UH Nottingham, U.K.
Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Edgbaston, B15 2TT Birmingham, Midlands, U.K.

Wolfgang Guba (W)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
ORCID: 0000-0002-3285-5957

Xiaoting Li (X)

iHuman Institute, ShanghaiTech University, 201210 Shanghai, China.
School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China.

Calvin Höffelmeyer (C)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Axel Hentsch (A)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Thais Gazzi (T)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Yelena Mostinski (Y)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Malgorzata Wasinska-Kalwa (M)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Fabio de Molnier (F)

IRR Chemistry Hub and Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, EH16 4UU Edinburgh, U.K.

Cas van der Horst (C)

Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands.

Jens Peter von Kries (JP)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.

Marc Vendrell (M)

IRR Chemistry Hub and Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, EH16 4UU Edinburgh, U.K.

Tian Hua (T)

iHuman Institute, ShanghaiTech University, 201210 Shanghai, China.
School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China.

Dmitry B Veprintsev (DB)

Division of Physiology, Pharmacology & Neuroscience, School of Life Sciences, University of Nottingham, NG7 2UH Nottingham, U.K.
Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Edgbaston, B15 2TT Birmingham, Midlands, U.K.
ORCID: 0000-0002-3583-5409

Laura H Heitman (LH)

Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University and Oncode Institute, 2333 CC Leiden, The Netherlands.
ORCID: 0000-0002-1381-8464

Uwe Grether (U)

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
ORCID: 0000-0002-3164-9270

Marc Nazare (M)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
ORCID: 0000-0002-1602-2330

Classifications MeSH